Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc.(ACHC)股票分析

$31.670

+1.507 (+4.76%)收盤時

Loading chart…
最高
31.895
開盤
29.840
成交量加權均價
31.14
成交量
1.93M
市值
6.31B
最低
29.840
成交金額
60.04M
企業價值/稅息折舊攤銷前利潤(TTM)
9.47

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. The Company owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the United States and Puerto Rico. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its CTCs specialize in providing medication-assisted treatment in an outpatient setting. Its specialty treatment facilities primarily consist of residential recovery facilities. It provides a comprehensive continuum of care for adults with addictive disorders and co-occurring mental disorders. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting.

AI 分析 of Acadia Healthcare Company, Inc. (ACHC)

買進

Acadia Healthcare Company Inc (ACHC) appears to be a good buy right now due to its current price of $29.25, which is below the analyst price target of $39, indicating significant upside potential. Additionally, the company has shown a strong year-to-date change of +104.69%, reflecting robust performance. However, a key risk is the negative sentiment from hedge funds, which have increased selling by 194.77% over the last quarter.

分析師評級(17)

-42.85% 下跌空間
買進
10 買進
7 持有
0 賣出
目前: 31.67
最低
13.00
平均
18.10
最高
25.00

Raymond James

2026-09-28

目標價

$39

優於大盤

Leerink

2026-09-23

目標價

$33

Market Perform

Guggenheim

2026-07-30

目標價

$39

買進

Barclays

2026-07-30

目標價

$32

Equal Weight

BofA

2026-07-29

目標價

$13

落後大盤

估值指標

Acadia Healthcare Company, Inc.(ACHC)目前預期本益比為 15.24,5 年平均預期本益比為 17.91。

預期本益比

合理
5 年均值 P/E
17.91
目前P/E
15.24
高估
23.58
低估
12.25

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
9.80
目前EV/EBITDA
9.47
高估
13.96
低估
5.63

預期股價營收比

低估
5 年均值 P/S
1.66
目前P/S
0.81
高估
2.47
低估
0.86

Alphio AI 對 ACHC 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%ACHC

$29.90

情境價格

基

基準

基準 · 50%ACHC

$25.39

情境價格

悲

悲觀

悲觀 · 25%ACHC

$23.05

情境價格

持有 ACHC 的大戶

B

Braidwell LP

+ 持有ACHC

+13.80%

3個月報酬率

A

Abrams Bison Investments, L.L.C.

+ 持有ACHC

+1.71%

3個月報酬率

G

Greenlight Capital, Inc.

+ 持有ACHC

-8.03%

3個月報酬率

D

Deerfield Management Company, L.P.

+ 持有ACHC

-8.23%

3個月報酬率

ACHC 常見問題 —— 由 Alphio AI 解答

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. The Company owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the United States and Puerto Rico. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its CTCs specialize in providing medication-assisted treatment in an outpatient setting. Its specialty treatment facilities primarily consist of residential recovery facilities. It provides a comprehensive continuum of care for adults with addictive disorders and co-occurring mental disorders. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. It operates in the Healthcare sector (SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC industry).

Acadia Healthcare Company Inc (ACHC) appears to be a good buy right now due to its current price of $29.25, which is below the analyst price target of $39, indicating significant upside potential. Additionally, the company has shown a strong year-to-date change of +104.69%, reflecting robust performance. However, a key risk is the negative sentiment from hedge funds, which have increased selling by 194.77% over the last quarter.

17 analysts cover ACHC: 10 rate it Buy, 7 Hold and 0 Sell. The average price target is 18.10.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易